格隆汇6月30日丨领航医药生物科技(00399.HK)宣布,于2025年6月30日,公司(作为买方)已与卖方及Conflux订立谅解备忘录,内容有关收购目标公司全部股权的潜在收购事项,前提为目标公司按照与公司的协议完成收购Conflux资产。Conflux为一间于香港注册成立的有限公司,主要从事开发区块链技术。于本公告日期,执行董事伍鸣博士亦为Conflux的董事及Conflux的唯一最终实益拥有...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.